<DOC>
	<DOC>NCT00337402</DOC>
	<brief_summary>Results about effects of symptomatic treatment on QoL appears conflicting in ALS patients. Moreover no clear effects of gastrotomy have be shown on survival. Prospective study on effect of tube feeding, QoL and survival is performed in 17 teaching hospitals in France (observational study)</brief_summary>
	<brief_title>Effects of Gastrostomy on Amyotrophic Lateral Sclerosis</brief_title>
	<detailed_description>Following data have been recorded each three months: QoL (MOS-SF 36 and ALSAQ), bodily mass index, testing and ALS-FRS scale, functional respiratory measures, impedance analysis, and the time for tube feeding procedure, the conditions of the acceptance and side-effects of gastrotomy</detailed_description>
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Motor Neuron Disease</mesh_term>
	<mesh_term>Amyotrophic Lateral Sclerosis</mesh_term>
	<criteria>patients &gt; 18 yearsold ALS certain or probable vital capacity (respiratory) &gt; 70 % under riluzole ALS in family other conditions affected survival and QoL cognitive impairment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2006</verification_date>
	<keyword>Gastrostomy</keyword>
	<keyword>Quality of life</keyword>
</DOC>